drugset / Trial / NCT04948372
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
RandomizedParallel-groupOpen-labelTreatment
Summary
This open-label, randomized controlled trial aimed to investigate the effect of a fixed dose of terlipressin added to usual care vs. usual care alone on renal perfusion in patients with septic shock.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-05-31
- Completion
- 2020-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terlipressin | Peptide | 1.3 ug/kg | Intravenous |